Everest Medicines Limited (1952.HK)
1952.HK Stock Price Chart
Explore Everest Medicines Limited interactive price chart. Choose custom timeframes to analyze 1952.HK price movements and trends.
1952.HK Company Profile
Discover essential business fundamentals and corporate details for Everest Medicines Limited (1952.HK) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
9 Oct 2020
Employees
665.00
Website
https://www.everestmedicines.comCEO
Yongqing Luo
Description
Everest Medicines Limited, a biopharmaceutical company, engages in discovery, licensing, clinical development, and commercialization of therapies to address critical unmet medical needs in Greater China and other Asia Pacific markets. Its pipeline products include eleven clinical-stage drug candidates for the treatment of oncology, immunology, cardio-renal, and infectious diseases. Everest Medicines Limited was incorporated in 2017 and is headquartered in Shanghai, China.
1952.HK Financial Timeline
Browse a chronological timeline of Everest Medicines Limited corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 25 Mar 2026
Upcoming earnings on 25 Mar 2026
Earnings released on 28 Aug 2025
Earnings released on 27 Aug 2025
EPS came in at -$0.84 surpassing the estimated -$1.11 by +23.76%, while revenue for the quarter reached $488.86M , missing expectations by -18.28%.
Earnings released on 25 Mar 2025
EPS came in at -$0.67 surpassing the estimated -$1.34 by +49.99%, while revenue for the quarter reached $215.51M , missing expectations by -50.04%.
Earnings released on 2 Mar 2025
EPS came in at -$0.70 , while revenue for the quarter reached $224.17M .
Earnings released on 28 Aug 2024
EPS came in at -$1.05 surpassing the estimated -$1.09 by +3.45%, while revenue for the quarter reached $161.90M , missing expectations by -40.38%.
Earnings released on 28 Jun 2024
EPS came in at -$1.06 , while revenue for the quarter reached $163.11M .
Earnings released on 28 Mar 2024
EPS came in at -$0.72 surpassing the estimated -$1.91 by +62.46%, while revenue for the quarter reached $64.77M , missing expectations by -91.09%.
Earnings released on 4 Mar 2024
EPS came in at -$0.70 , while revenue for the quarter reached $62.77M .
Earnings released on 24 Aug 2023
EPS came in at -$0.76 surpassing the estimated -$2.28 by +66.74%, while revenue for the quarter reached $4.81M , missing expectations by -69.17%.
Earnings released on 31 Mar 2023
EPS came in at $0.80 , while revenue for the quarter reached $6.69M , missing expectations by -98.78%.
Earnings released on 31 Mar 2023
EPS came in at -$0.80 , while revenue for the quarter reached $5.08M .
Earnings released on 30 Sept 2022
EPS came in at $0.77 falling short of the estimated $2.46 by -68.62%, while revenue for the quarter reached $6.45M , missing expectations by -99.71%.
Earnings released on 25 Aug 2022
EPS came in at -$1.39 surpassing the estimated -$2.17 by +35.76%, while revenue for the quarter reached $643.32K , missing expectations by -95.72%.
Earnings released on 30 Jun 2022
EPS came in at -$1.32 , while revenue for the quarter reached $611.09K .
Earnings released on 29 Mar 2022
EPS came in at -$1.29 surpassing the estimated -$5.00 by +74.22%, while revenue for the quarter reached $32.57K .
Earnings released on 31 Dec 2021
EPS came in at -$1.31 , while revenue for the quarter reached $33.06K .
Earnings released on 31 Aug 2021
EPS came in at -$0.77 surpassing the estimated -$1.61 by +52.01%.
Earnings released on 30 Jun 2021
EPS came in at -$0.78 .
Earnings released on 22 Mar 2021
EPS came in at -$13.37 .
Earnings released on 31 Dec 2020
EPS came in at -$20.50 .
Earnings released on 25 Sept 2020
EPS came in at $2.34 .
1952.HK Stock Performance
Access detailed 1952.HK performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.